DAVID SMITH: Open Payments
NPI 1194272245 · PROVO, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$193 in 8 payments from 6 companies in 2025. Trend: 2023 $227 · 2024 $565 · 2025 $193
Food & beverage: $193
| Company | Payments | Amount |
|---|---|---|
| Merz Pharmaceuticals, LLC | 2 | $70 |
| Boston Scientific Corporation | 2 | $40 |
| Averitas Pharma Inc. | 1 | $25 |
| Medtronic, Inc. | 1 | $21 |
| Alkermes, Inc. | 1 | $19 |
| ABBVIE INC. | 1 | $18 |
Products named: Xeomin, QUTENZA, WaveWriter Alpha Prime 16, INCEPTIV, ARISTADA, General - Therapies, QULIPTA.
Industry payments across UT — which companies pay providers there.
